Xiang Luo
Clinical trials sponsored by Xiang Luo, explained in plain language.
-
New combo therapy shows promise in preventing stroke worsening
Disease control CompletedThis study tested whether giving a powerful cholesterol-lowering drug (evolocumab) along with standard statins within 48 hours of a stroke could prevent early neurological decline. It included 429 adults with moderate to severe narrowing of brain arteries. The goal was to see if …
Phase: PHASE2, PHASE3 • Sponsor: Xiang Luo • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
Can a simple heparin shot save stroke Patients' arteries?
Disease control CompletedThis study tested whether giving heparin (a blood thinner) during brain angiography can prevent the radial artery in the wrist from becoming blocked afterward. The trial involved 440 acute stroke patients and compared heparin to a placebo. The goal was to see if heparin reduces a…
Phase: PHASE3 • Sponsor: Xiang Luo • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Stroke drug tirofiban may boost recovery after clot removal
Disease control CompletedThis study tested whether giving the blood-thinning drug tirofiban after mechanical clot removal improves outcomes for people with severe stroke. Over 1,300 participants were randomly assigned to receive tirofiban or a placebo. The goal was to see if more patients could live inde…
Phase: PHASE2, PHASE3 • Sponsor: Xiang Luo • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC